New members the NIHR Oxford and Oxford Health BRCs’ Diversity in Research Group attended a meeting on 31 January to learn about the work of the two BRCs and how they can play a crucial role in making research more reflective of the society it seeks to help. The Diversity in Research Group was ... READ MORE
News
Critical role of GP data in understanding common heart condition highlighted
A study led by Oxford researchers has identified 28 percent more cases of atrial fibrillation, a common and serious cardiac condition, in primary care data than secondary care data alone. Evidence of atrial fibrillation was also recorded an average of 1.3 years earlier. The findings - published ... READ MORE
Scientists create new way to predict bowel cancer risk in people with IBD
Researchers have found a way to identify people with inflammatory bowel disease (IBD) who are at the highest risk of developing bowel cancer. IBD, which affects around 500,000 people in the UK, includes ulcerative colitis and Crohn’s disease. They irritate the lining of the bowel, which can ... READ MORE
Oxford and GSK launch £50million programme to advance novel cancer research
Leading NIHR Oxford Biomedical Research Centre researchers will play a key role in a major new collaboration between the University of Oxford and global biopharma company GSK to advance the understanding of how cancer develops, which could inform future development of vaccines to prevent ... READ MORE
BRC-supported rheumatologist receives prestigious NIHR professorship
An Oxford BRC-supported researcher has become the first rheumatologist to be awarded a prestigious Research Professorship from the National Institute for Health and Care Research (NIHR). Professor Laura Coates (pictured), a Senior Clinical Research Fellow in the Nuffield Department of ... READ MORE
Blood test developed to allow early detection of multiple cancers
Researchers at the University of Oxford have unveiled a new blood test – powered by machine learning – which shows real promise in detecting multiple types of cancer in their earliest stages, when the disease is hardest to detect. Named TriOx, this innovative liquid biopsy test analyses ... READ MORE
Oxford to play key role in two new MRC gene therapy centres
The Medical Research Council (MRC), part of UKRI, is launching its first two Centres of Research Excellence (CoRE), which will develop transformative new advanced therapeutics for currently untreatable diseases. Oxford is leading one of these centres and co-leading the other. Together, these ... READ MORE
Collaboration evaluates new drug for treatment of autonomous cortisol secretion
Scientists from the Universities of Oxford and Sheffield are collaborating with the US biopharmaceutical company Sparrow Pharmaceuticals on DC-MACS a Phase 2 clinical study of the drug clofutriben to treat autonomous cortisol secretion (ACS). Clofutriben, also known as SPI-62, is produced by ... READ MORE
Wearable devices can help predict five-year risk of falls for people with Parkinson’s
University of Oxford researchers have demonstrated how clinicians could use data to predict the risk of falls in people with Parkinson’s disease (PD) to help improve effective longer-term care planning. Falls are a common problem for people living with Parkinson’s. A recent review estimated ... READ MORE
Machine learning outperforms surgeons in predicting knee replacement outcomes
A new study has revealed that machine learning models can significantly outperform experienced surgeons in predicting patient outcomes after partial knee replacement. Unicompartmental (partial) knee replacement (UKR) is a common procedure designed to relieve pain in patients with knee ... READ MORE
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- 6
- …
- 91
- Next Page »